Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-03 @ 9:02 PM
Study NCT ID:
NCT05506956
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2022-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Post-transplant Flotetuzumab for AML
Sponsor:
Organization: